Opportunistic Infections Citation List: September 13 - September 26, 2013
ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Identification and Structure Elucidation of a Novel Antifungal Compound Produced by Pseudomonas aeruginosa PGPR2 against Macrophomina phaseolina. Illakkiam, D., P. Ponraj, M. Shankar, S. Muthusubramanian, J. Rajendhran, and P. Gunasekaran. Applied Biochemistry and Biotechnology, 2013. [Epub ahead of print]. PMID[24037513].
[PubMed]. OI_0913-092613.
2. In Vitro Effectiveness of Anidulafungin against Candida Sp. Biofilms. Rosato, A., M. Piarulli, B.P. Schiavone, A. Catalano, A. Carocci, A. Carrieri, A. Carone, G. Caggiano, C. Franchini, F. Corbo, and M.T. Montagna. The Journal of Antibiotics, 2013. [Epub ahead of print]. PMID[24022607].
[PubMed]. OI_0913-092613.
3. Susceptibility Profile of a Brazilian Yeast Stock Collection of Candida Species Isolated from Subjects with Candida-associated Denture Stomatitis with or without Diabetes. Sanita, P.V., E.G. de Oliveira Mima, A.C. Pavarina, J.H. Jorge, A.L. Machado, and C.E. Vergani. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2013. [Epub ahead of print]. PMID[24055150].
[PubMed]. OI_0913-092613.
4. Antimicrobial Ergosteroids and Pyrrole Derivatives from Halotolerant Aspergillus flocculosus PT05-1 Cultured in a Hypersaline Medium. Zheng, J., Y. Wang, J. Wang, P. Liu, J. Li, and W. Zhu. Extremophiles, 2013. [Epub ahead of print]. PMID[24030481].
[PubMed]. OI_0913-092613.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
5. Biphasic Mode of Antibacterial Action of Aminoglycoside Antibiotics-loaded Elastic Hydroxyapatite-glucan Composite. Belcarz, A., A. Zima, and G. Ginalska. International Journal of Pharmaceutics, 2013. 454(1): p. 285-295. PMID[23850627].
[PubMed]. OI_0913-092613.
6. Antibacterial Activity of and Resistance to Small Molecule Inhibitors of the CLPP Peptidase. Compton, C.L., K.R. Schmitz, R.T. Sauer, and J.K. Sello. ACS Chemical Biology, 2013. [Epub ahead of print]. PMID[24047344].
[PubMed]. OI_0913-092613.
7. In Vitro Cross-linking of Peptidoglycan by Mycobacterium tuberculosis L,D-transpeptidases and Inactivation of These Enzymes by Carbapenems. Cordillot, M., V. Dubee, S. Triboulet, L. Dubost, A. Marie, J.E. Hugonnet, M. Arthur, and J.L. Mainardi. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[24041897].
[PubMed]. OI_0913-092613.
8. IL-22 Inhibits Intracellular Growth of Mycobacterium tuberculosis by Enhancing Calgranulin A Expression. Dhiman, R., S. Venkatasubramanian, P. Paidipally, P.F. Barnes, A. Tvinnereim, and R. Vankayalapati. The Journal of Infectious Diseases, 2013. [Epub ahead of print]. PMID[24041785].
[PubMed]. OI_0913-092613.
9. ISPC as Target for Antiinfective Drug Discovery: Synthesis, Enantiomeric Separation and Structural Biology of Fosmidomycin Thia-isosters. Kunfermann, A., C. Lienau, B. Illarionov, J. Held, T. Grawert, C.T. Behrendt, P. Werner, S. Hahn, W. Eisenreich, U. Riederer, B. Mordmuller, A. Bacher, M. Fischer, M. Groll, and T. Kurz. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24032981].
[PubMed]. OI_0913-092613.
10. Medicinal Plants from Open-air Markets in the State of Rio De Janeiro, Brazil as a Potential Source of New Antimycobacterial Agents. Leitao, F., S.G. Leitao, M.Z. de Almeida, J. Cantos, T. Coelho, and P.E. da Silva. Journal of Ethnopharmacology, 2013. 149(2): p. 513-521. PMID[23871806].
[PubMed]. OI_0913-092613.
11. Antimycobacterial Activity of Cyclic Dipeptides Isolated from Bacillus sp. N Strain Associated with Entomopathogenic Nematode. Nishanth Kumar, S. and C. Mohandas. Pharmaceutical Biology, 2013. [Epub ahead of print]. PMID[24047443].
[PubMed]. OI_0913-092613.
12. Design and Synthesis of Positional Isomers of 5 and 6-Bromo-1-[(phenyl)sulfonyl]-2-[(4-nitrophenoxy)methyl]-1H-benzimidazoles as Possible Antimicrobial and Antitubercular Agents. Ranjith, P.K., P. Rajeesh, K.R. Haridas, N.K. Susanta, T.N. Guru Row, R. Rishikesan, and N. Suchetha Kumari. Bioorganic & Medicinal Chemistry Letters, 2013. 23(18): p. 5228-5234. PMID[23942420].
[PubMed]. OI_0913-092613.
13. The DPRE1 Enzyme, One of the Most Vulnerable Targets of Mycobacterium tuberculosis. Riccardi, G., M.R. Pasca, L.R. Chiarelli, G. Manina, A. Mattevi, and C. Binda. Applied Microbiology and Biotechnology, 2013. [Epub ahead of print]. PMID[24037308].
[PubMed]. OI_0913-092613.
14. Structure-activity Studies of Divin: An Inhibitor of Bacterial Cell Division. Zhou, M., Y.J. Eun, I.A. Guzei, and D.B. Weibel. ACS Medicinal Chemistry Letters, 2013. 4(9): p. 880-885. PMID[24044050].
[PubMed]. OI_0913-092613.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
15. Protective Humoral Immunity Elicited by a Needle-free Malaria Vaccine Comprised of a Chimeric P. falciparum Circumsporozoite Protein and the TLR5 Agonist Flagellin. Carapau, D., R. Mitchell, A. Nacer, A. Shaw, C. Othoro, U. Frevert, and E. Nardin. Infection and Immunity, 2013. [Epub ahead of print]. PMID[24042110].
[PubMed]. OI_0913-092613.
16. Thiaplakortones A-D, Antimalarial Thiazine Alkaloids from the Australian Marine Sponge Plakortis lita. Davis, R.A., S. Duffy, S. Fletcher, V.M. Avery, and R.J. Quinn. The Journal of Organic Chemistry, 2013. [Epub ahead of print]. PMID[24032556].
[PubMed]. OI_0913-092613.
17. Differential Adhesion-inhibitory Patterns of Antibodies Raised against Two Major Variants of the NTS-DBL2X Region of VAR2CSA. Doritchamou, J., P. Bigey, M.A. Nielsen, S. Gnidehou, S. Ezinmegnon, A. Burgain, A. Massougbodji, P. Deloron, A. Salanti, and N.T. Ndam. Vaccine, 2013. 31(41): p. 4516-4522. PMID[23933341].
[PubMed]. OI_0913-092613.
18. Investigation of Acyclic Uridine Amide and 5'-Amido nucleoside Analogues as Potential Inhibitors of the Plasmodium falciparum Dutpase. Hampton, S.E., A. Schipani, C. Bosch-Navarrete, E. Recio, M. Kaiser, P. Kahnberg, D. Gonzalez-Pacanowska, N.G. Johansson, and I.H. Gilbert. Bioorganic & Medicinal Chemistry, 2013. 21(18): p. 5876-5885. PMID[23916149].
[PubMed]. OI_0913-092613.
19. In Vitro and in Vivo Antimalarial Activity and Cytotoxicity of Extracts and Fractions from the Leaves, Root-bark and Stem-bark of Triclisia gilletii. Kikueta, C.M., O.K. Kambu, A.P. Mbenza, S.T. Mavinga, B.M. Mbamu, P. Cos, L. Maes, S. Apers, L. Pieters, and R.K. Cimanga. Journal of Ethnopharmacology, 2013. 149(2): p. 438-442. PMID[23876596].
[PubMed]. OI_0913-092613.
20. Functional Comparison of Plasmodium falciparum Transmission-blocking Vaccine Candidates by the Standard Membrane-feeding Assay. Miura, K., E. Takashima, B. Deng, G. Tullo, A. Diouf, S.E. Moretz, D. Nikolaeva, M. Diakite, R.M. Fairhurst, M.P. Fay, C.A. Long, and T. Tsuboi. Infection and Immunity, 2013. [Epub ahead of print]. PMID[24042109].
[PubMed]. OI_0913-092613.
21. Immunogenicity of Single Versus Mixed Allele Vaccines of Plasmodium vivax Duffy Binding Protein Region II. Ntumngia, F.B., J. Schloegel, A.M. McHenry, S.J. Barnes, M.T. George, S. Kennedy, and J.H. Adams. Vaccine, 2013. 31(40): p. 4382-4388. PMID[23916294].
[PubMed]. OI_0913-092613.
22. Screening of Novel Malaria DNA Vaccine Candidates Using Full-length CDNA Library. Shibui, A., S. Nakae, J. Watanabe, Y. Sato, M.E. Tolba, J. Doi, T. Shiibashi, S. Nogami, S. Sugano, and N. Hozumi. Experimental Parasitology, 2013. [Epub ahead of print]. PMID[24055215].
[PubMed]. OI_0913-092613.
23. Antiplasmodium Activity and Mechanism of Action of RSM-932A, a Promising Synergistic Inhibitor of Plasmodium falciparum Choline Kinase. Zimmerman, T., C. Moneriz, A. Diez, J.M. Bautista, T.G. Del Pulgar, A. Cebrian, and J.C. Lacal. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[24041883].
[PubMed]. OI_0913-092613.
ANTIPROTOZOAL COMPOUNDS
24. Characterization of a Serine Hydrolase Targeted by Acyl-protein Thioesterase Inhibitors in Toxoplasma gondii. Kemp, L.E., M. Rusch, A. Adibekian, H.E. Bullen, A. Graindorge, C. Freymond, M. Rottmann, C. Braun-Breton, S. Baumeister, A.T. Porfetye, I.R. Vetter, C. Hedberg, and D. Soldati-Favre. The Journal of Biological Chemistry, 2013. 288(38): p. 27002-27018. PMID[23913689].
[PubMed]. OI_0913-092613.
Citations from the ISI Web of Knowledge Listings for O.I.
25. Effect of Schinus terebinthifolius on Candida albicans Growth Kinetics, Cell Wall Formation and Micromorphology. Alves, L.A., I.D. Freires, T.M. Pereira, A. de Souza, E.D. Lima, and R.D. de Castro. Acta Odontologica Scandinavica, 2013. 71(3-4): p. 965-971. ISI[000322832200085].
[WOS]. OI_0913-092613.
26. Bronsted Acidic Ionic Liquid Catalysis: An Efficient and Eco-friendly Synthesis of Novel Fused Pyrano pyrimidinones and Their Antimicrobial Activity. Banothu, J., R. Gali, R. Velpula, and R. Bavantula. Journal of Chemical Sciences, 2013. 125(4): p. 843-849. ISI[000323532800019].
[WOS]. OI_0913-092613.
27. Mycobacterium tuberculosis Shikimate Kinase Inhibitors: Design and Simulation Studies of the Catalytic Turnover. Blanco, B., V. Prado, E. Lence, J.M. Otero, C. Garcia-Doval, M.J. van Raaij, A.L. Llamas-Saiz, H. Lamb, A.R. Hawkins, and C. Gonzalez-Bello. Journal of the American Chemical Society, 2013. 135(33): p. 12366-12376. ISI[000323536100036].
[WOS]. OI_0913-092613.
28. Whole Cell Screen for Inhibitors of pH Homeostasis in Mycobacterium tuberculosis. Darby, C.M., H.I. Ingolfsson, X.J. Jiang, C. Shen, M.N. Sun, N. Zhao, K. Burns, G. Liu, S. Ehrt, J.D. Warren, O.S. Anderson, S.J. Brickner, and C. Nathan. Plos One, 2013. 8(7): p. e68942. ISI[000323114200017].
[WOS]. OI_0913-092613.
29. Identification of an Aminothiazole with Antifungal Activity against Intracellular Histoplasma capsulatum. Edwards, J.A., M.M. Kemski, and C.A. Rappleye. Antimicrobial Agents and Chemotherapy, 2013. 57(9): p. 4349-4359. ISI[000323285500033].
[WOS]. OI_0913-092613.
30. Regioselective Synthesis, Characterization and Antimicrobial Evaluation of S-glycosides and S,N-diglycosides of 1,2-Dihydro-5-(1H-indol-2-yl)-1,2,4-triazole-3-thione. El Ashry, E.H., E.H. El Tamany, M.E. Abd El Fattah, A.T.A. Boraei, and H.M. Abd El-Nabi. European Journal of Medicinal Chemistry, 2013. 66: p. 106-113. ISI[000323628500011].
[WOS]. OI_0913-092613.
31. Synthesis and Structure-Activity Relationships Evaluation of Benzothiazinone Derivatives as Potential Anti-tubercular Agents. Gao, C., T.H. Ye, N.Y. Wang, X.X. Zeng, L.D. Zhang, Y. Xiong, X.Y. You, Y. Xia, Y. Xu, C.T. Peng, W.Q. Zuo, Y.Q. Wei, and L.T. Yu. Bioorganic & Medicinal Chemistry Letters, 2013. 23(17): p. 4919-4922. ISI[000323187000033].
[WOS]. OI_0913-092613.
32. Selective Peptide Inhibitors of Bifunctional Thymidylate Synthase-dihydrofolate Reductase from Toxoplasma gondii Provide Insights into Domain-domain Communication and Allosteric Regulation. Landau, M.J., H. Sharma, and K.S. Anderson. Protein Science, 2013. 22(9): p. 1161-1173. ISI[000323410100002].
[WOS]. OI_0913-092613.
33. Antifungal Activity of Phlorotannins against Dermatophytes and Yeasts: Approaches to the Mechanism of Action and Influence on Candida albicans Virulence Factor. Lopes, G., E. Pinto, P.B. Andrade, and P. Valentao. Plos One, 2013. 8(8): p. e72203. ISI[000323097300183].
[WOS]. OI_0913-092613.
34. Synthesis and Binary QSAR Study of Antitubercular Quinolylhydrazides. Manvar, A., V. Khedkar, J. Patel, V. Vora, N. Dodia, G. Patel, E. Coutinho, and A. Shah. Bioorganic & Medicinal Chemistry Letters, 2013. 23(17): p. 4896-4902. ISI[000323187000029].
[WOS]. OI_0913-092613.
35. Transient Expression and Characterization of the Antimicrobial Peptide Protegrin-1 in Nicotiana tabacum for Control of Bacterial and Fungal Mammalian Pathogens. Patino-Rodriguez, O., B. Ortega-Berlanga, Y.Y. Llamas-Gonzalez, M.A. Flores-Valdez, A. Herrera-Diaz, R. Montes-de-Oca-Luna, S.S. Korban, and A.G. Alpuche-Solis. Plant Cell Tissue and Organ Culture, 2013. 115(1): p. 99-106. ISI[000323386400009].
[WOS]. OI_0913-092613.
36. 7-Hydroxy-(E)-3-phenylmethylene-chroman-4-one Analogues as Efflux Pump Inhibitors against Mycobacterium smegmatis mc2 155. Roy, S.K., N. Kumari, S. Gupta, S. Pahwa, H. Nandanwar, and S.M. Jachak. European Journal of Medicinal Chemistry, 2013. 66: p. 499-507. ISI[000323628500051].
[WOS]. OI_0913-092613.
37. Efficacy of Amphotericin B at Suboptimal Dose Combined with Voriconazole in a Murine Model of Aspergillus fumigatus Infection with Poor in Vivo Response to the Azole. Sandoval-Denis, M., F.J. Pastor, J. Capilla, and J. Guarro. Antimicrobial Agents and Chemotherapy, 2013. 57(9): p. 4540-4542. ISI[000323285500060].
[WOS]. OI_0913-092613.
38. Inhibitory Effect of Sodium metabisulphite and Chlorine on Growth of Aspergillus spp. And Penicillium spp. Strains Isolated from Marine Shrimp. Santos, Y.F.D., A.P.B. Veloso, R.M. Calvet, M.M.G. Pereira, C.M. Pereyra, A.M. Dalcero, A.M. Torres, and M.C.S. Muratori. Ciencia Rural, 2013. 43(9): p. 1721-1726. ISI[000323338400029].
[WOS]. OI_0913-092613.
39. Chloroquine Sensitizes Biofilms of Candida albicans to Antifungal Azoles. Shinde, R.B., J.S. Raut, N.M. Chauhan, and S.M. Karuppayil. Brazilian Journal of Infectious Diseases, 2013. 17(4): p. 395-400. ISI[000323336800002].
[WOS]. OI_0913-092613.
40. Purification and Chemical Characterization of Antimicrobial Compounds from a New Soil Isolate Streptomyces rimosus MTCC 10792. Singh, N., V. Rai, and C.K.M. Tripathi. Applied Biochemistry and Microbiology, 2013. 49(5): p. 473-480. ISI[000323701000005].
[WOS]. OI_0913-092613.
41. Activity of Antifungal Combinations against Aspergillus Species Evaluated by Isothermal Microcalorimetry. Tafin, U.F., C. Orasch, and A. Trampuz. Diagnostic Microbiology and Infectious Disease, 2013. 77(1): p. 31-36. ISI[000323467700007].
[WOS]. OI_0913-092613.
42. Synthesis and Biological Activity of Benzo-fused 7-deazaadenosine Analogues. 5- and 6-Substituted 4-amino- or 4-alkylpyrimido[4,5-b]indole ribonucleosides. Tichy, M., R. Pohl, E. Tloust'ova, J. Weber, G. Bahador, Y.J. Lee, and M. Hocek. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 5362-5372. ISI[000323294600054].
[WOS]. OI_0913-092613.